bioMérieux S.A. (BIM.PA) stock analysis

In our weekly check, bioMérieux S.A. is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 15 pass, warnings: 8, red flags: 2.

About bioMérieux S.A.

bioMérieux S.A. is a Healthcare company (Medical - Diagnostics & Research) based in France, listed on PAR as BIM.PA.

What our checks show for BIM.PA

Red flags

• The net margin fell by 8 points over 5 years, to 9.8%: the company keeps less of each sale as profit.
• The gross margin fell by 5.7 points, to 52.6%: costs are rising faster than prices.

Warning signs

• Analysts expect only about 4.2% a year of growth in revenue.
• Revenue grew only 4.3% a year over the last 3 years.
• Earnings per share fell 4.3% a year over the last 3 years.
• Net profit fell 4.2% a year over the last 3 years.
• The net margin is only 9.8%: little room if costs rise.
• The stock has fallen as much as 54% from a peak. Would you have held through that?
• The stock is still below its previous peak.
• Thinly traded (about 164 thousand shares a day): buying and selling can move the price.

Strengths

• Debt is low: 0.1x equity.
• Operating profit covers interest 39.6 times over.
• Operating cash flow is 1.98x net profit: the profit arrives as real cash.
• Analysts expect earnings per share to grow about 15.3% a year over the next years.
• Analysts expect the net margin to improve by 3.2 points from today's 9.8%.
• Free cash flow is 11.1% of revenue: cash for dividends, buybacks or growth.

Similar companies

QGEN · ERF.PA · ICLR · CRL · RVTY · GRAL

Questions

What grade does bioMérieux S.A. (BIM.PA) have?

In our weekly check, bioMérieux S.A. is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 15 pass, warnings: 8, red flags: 2. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of BIM.PA stock?

This week's biggest flags for bioMérieux S.A.: Margins falling, Gross margin falling, Weak revenue forecast. In total 10 of 25 checks show a warning or a red flag.

What does bioMérieux S.A. do?

bioMérieux S.A. is a Healthcare company (Medical - Diagnostics & Research) based in France, listed on PAR as BIM.PA.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-31

Open the full analysis